000 01261 a2200361 4500
005 20250515095104.0
264 0 _c20080214
008 200802s 0 0 eng d
022 _a0277-0008
024 7 _a10.1592/phco.27.12.1711
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKhan, Fida A
245 0 0 _aCandida endophthalmitis: focus on current and future antifungal treatment options.
_h[electronic resource]
260 _bPharmacotherapy
_cDec 2007
300 _a1711-21 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAmphotericin B
_xtherapeutic use
650 0 4 _aAntifungal Agents
_xtherapeutic use
650 0 4 _aCandidiasis
_xdiagnosis
650 0 4 _aEchinocandins
_xtherapeutic use
650 0 4 _aEndophthalmitis
_xdiagnosis
650 0 4 _aFluconazole
_xtherapeutic use
650 0 4 _aFlucytosine
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aPyrimidines
_xtherapeutic use
650 0 4 _aRisk Factors
650 0 4 _aTriazoles
_xtherapeutic use
650 0 4 _aVoriconazole
700 1 _aSlain, Douglas
700 1 _aKhakoo, Rashida A
773 0 _tPharmacotherapy
_gvol. 27
_gno. 12
_gp. 1711-21
856 4 0 _uhttps://doi.org/10.1592/phco.27.12.1711
_zAvailable from publisher's website
999 _c17556940
_d17556940